NEW STEP BY STEP MAP FOR HEMGENIX

Number of eligible patients: CDEC mentioned the uncertainty in the amount of individuals with moderately severe to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some individuals who are categorised as owning moderate or reasonable condition might have a serious bleeding